HSCA Support Letter to the House Committee on Energy & Commerce on House Passage of FDA User Fee Reauthorizations
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), we applaud the bipartisan leadership of Chairman Pallone, Chairwoman Eshoo, Ranking Member Rodgers, and Ranking Member Guthrie of the House Committee on Energy & Commerce on the Food and Drug Amendments Act of 2022, which the House of Representatives recently passed with overwhelming support by a vote of 392-28. Timely access to safe and effective drugs, devices, products, and biologics for all Americans is of critical importance to GPOs, which serve as the sourcing partners to virtually all hospitals, clinics, ambulatory surgery centers, and long-term care facilities.
Click here to read the full letter.
Lear MoreANALYSIS: GPOs Helped Increase Domestic Manufacturing Capacity, Protected Hospitals and Patients from Thousands of Fraudulent Sellers, and Helped Identify and Bring New Suppliers to Market to Avert Supply and Drug Shortages During COVID-19
HSCA Releases Issue Brief Detailing Learnings and Best Practices from Industry COVID-19 Response.
Click here to read the full comments.
HSCA Comments to the Senate Committee on Health, Education, Labor, and Pensions on the PREVENT Pandemics Act
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), we appreciate the opportunity to comment on the Committee’s draft text of the ‘Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act’ (PREVENT Pandemics Act).
Click here to read the full comments.
Lear MoreHSCA ANNOUNCES 2022 BOARD OF DIRECTORS AND NAMES CHILDREN’S HOSPITAL ASSOCIATION VICE PRESIDENT JENNIFER GEDNEY BOARD CHAIR
Washington, DC (January 4, 2022) – The Healthcare Supply Chain Association (HSCA) today announced that Children’s Hospital Association Vice President of Supply Chain Services Jennifer Gedney will serve as Chair of HSCA’s Board of Directors, replacing Vizient President and Chief Operating Officer (COO) Bharat Sundaram, who will serve as Immediate Past Chair.
“Jennifer Gedney has long been recognized as an industry leader with a deep commitment to serving patients,” said HSCA President and CEO Todd Ebert, R.PH. “Jennifer’s expertise and dedication will help HSCA and its members navigate the challenges of the COVID-19 pandemic at a critical moment for the healthcare system, allowing healthcare providers to focus on their core mission: providing first-class patient care.”
Click here to read the full release.
Lear MoreHSCA RELEASES HEALTHCARE CYBERSECURITY KEY CONSIDERATIONS TO HELP PROTECT PATIENT HEALTH, SAFETY, AND PRIVACY
Washington, DC (December 21, 2021) – The Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), today released key cybersecurity considerations for medical device manufacturers, healthcare delivery organizations, and service providers to help safeguard patient health, safety, and privacy. In conjunction with the release of the key considerations, HSCA also published “Recommendations for Medical Device Cybersecurity Terms and Conditions,” which details potential purchasing contract terms and conditions that could help ensure rapid adoption of rigorous cybersecurity measures.
“The widespread adoption of telemedicine and rapid shift to virtual operations during the COVID-19 pandemic has underscored the important role that information technology, software, and medical devices can play in improving patient care. However, as evidenced by recent cyberattacks, medical devices and services are vulnerable to cybersecurity threats that could jeopardize patient health, safety, and privacy,” said HSCA President and CEO Todd Ebert, R. Ph. “GPOs leverage their unique line of sight over the supply chain to help providers harness the benefits of technology to care for their patients while guarding against cyber threats.”
Click here to read the full release.
Lear MoreHSCA Comments to FDA Regarding FDA’s List of Public Health Focused Essential Medicines
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments to the U.S. Food and Drug Administration (FDA) regarding FDA’s recently published list of essential medicines, medical countermeasures (MCM), and their critical inputs. HSCA and our member companies are committed to ensuring continued patient access to critical medical products.
Click here to read the full comments.
Lear MoreHSCA Comments to the Senate HELP Committee on Planning for the Next Pandemic
Dear Chairman Alexander and Ranking Member Murray:
On behalf of the Healthcare Supply Chain Association (HSCA), we applaud your leadership to promote U.S. public health preparedness and response. Through commitment to advancing recommendations to help prepare for the next pandemic, we can best work to provide critical support in emergencies facing this nation. The unprecedented nature of the COVID-19 pandemic requires a whole-of-nation effort to ensure a coordinated and comprehensive response.
Click here to read the full comments.
HSCA Statement on Senate HELP Committee Hearing on the Coronavirus
Washington, DC (March 3, 2020) – Healthcare Supply Chain Association (HSCA) President and CEO Khatereh Calleja today released the following statement in conjunction with “An Emerging Disease Threat: How the U.S. Is Responding to COVID-19, the Novel Coronavirus,” a hearing before the U.S. Senate Committee on Health, Education, Labor, and Pensions (HELP):
“HSCA and its member healthcare group purchasing organizations (GPOs) applaud Senate HELP Committee Chair Lamar Alexander (R-TN) and Ranking Member Patty Murray (D-WA) for their focus on the United States’ efforts to prevent the spread of the coronavirus.
“Public health crises like the coronavirus place enormous stress on the entire healthcare system, including first responders, physicians, hospitals, other healthcare providers, and the patients they serve. HSCA and its member GPOs are working closely with Congress, the Administration, federal agencies, and all healthcare stakeholders throughout the healthcare delivery system to safeguard the supply chain and ensure hospitals and healthcare providers are equipped to treat and prevent the spread of this disease.
Click here to read the full statement.
Lear MoreJoint Letter of Support for the MEDS Act
Dear Senator Collins and Senator Smith,
The undersigned organizations are writing in support of S.2723 – The Mitigating Emergency Drug Shortages (MEDS) Act. Drug shortages have been on the rise for several years, with an estimated 210 drugs currently at risk or not readily available for U.S. hospitals, according to the national database maintained by the American Society of Health System Pharmacists (ASHP). The Food and Drug Administration (FDA) also states that drug shortages have grown more persistent since 2014 with many shortages lasting multiple years.
Click here to read the full letter.
Lear MoreHSCA Applauds Senators Collins and Smith for Bipartisan Legislation to Prevent and Mitigate Drug Shortages
Washington, DC (October 30, 2019) – Healthcare Supply Chain Association (HSCA) President and CEO Khatereh Calleja today released the following statement applauding Senator Susan Collins (R-ME) and Senator Tina Smith (D-MN) and announcing HSCA’s support for The Mitigating Emergency Drug Shortages (MEDS) Act:
“HSCA and its member group purchasing organizations (GPOs) applaud Senators Collins and Smith for their bipartisan leadership in addressing drug shortages, reducing healthcare costs, and improving patient outcomes for Americans across the country. HSCA strongly supports the MEDS Act, which builds upon the important steps Congress has taken to provide additional authority to the FDA to help mitigate drug shortages and develop market-based incentives to ensure a stable supply of medications critical for patient care.
Click here to read the full statement.
Lear More